CN1675204A - 2－杂芳基甲酰胺 - Google Patents

2－杂芳基甲酰胺 Download PDF

Info

Publication number
CN1675204A
CN1675204A CNA038188511A CN03818851A CN1675204A CN 1675204 A CN1675204 A CN 1675204A CN A038188511 A CNA038188511 A CN A038188511A CN 03818851 A CN03818851 A CN 03818851A CN 1675204 A CN1675204 A CN 1675204A
Authority
CN
China
Prior art keywords
azabicyclo
oct
alkyl
mmol
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038188511A
Other languages
English (en)
Chinese (zh)
Inventor
J·卢伊特勒
F·－G·伯斯
C·埃尔布
F·－T·哈夫纳
K·施尼茨勒
T·弗勒斯纳
M·范坎彭
F·－J·范德施塔伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10257078A external-priority patent/DE10257078A1/de
Priority claimed from DE2002157537 external-priority patent/DE10257537A1/de
Priority claimed from DE10305922A external-priority patent/DE10305922A1/de
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of CN1675204A publication Critical patent/CN1675204A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
CNA038188511A 2002-06-10 2003-06-02 2－杂芳基甲酰胺 Pending CN1675204A (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE10225536 2002-06-10
DE10225536.9 2002-06-10
DE10257078A DE10257078A1 (de) 2002-12-06 2002-12-06 2-Heteroarylcarbonsäureamide
DE10257078.7 2002-12-06
DE2002157537 DE10257537A1 (de) 2002-12-10 2002-12-10 2-Heteroarylcarbonsäureamide
DE10257537.1 2002-12-10
DE10305922A DE10305922A1 (de) 2002-06-10 2003-02-13 2-Heteroarylcarbonsäureamide
DE10305922.9 2003-02-13

Publications (1)

Publication Number Publication Date
CN1675204A true CN1675204A (zh) 2005-09-28

Family

ID=29740887

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038188511A Pending CN1675204A (zh) 2002-06-10 2003-06-02 2－杂芳基甲酰胺

Country Status (16)

Country Link
US (5) US7977485B2 (https=)
EP (1) EP1515967B1 (https=)
JP (1) JP4542891B2 (https=)
CN (1) CN1675204A (https=)
AT (1) ATE344262T1 (https=)
AU (1) AU2003238450A1 (https=)
BR (1) BR0312446A (https=)
CA (1) CA2488761C (https=)
DE (1) DE50305587D1 (https=)
ES (1) ES2276072T3 (https=)
IL (1) IL165505A0 (https=)
MX (1) MXPA04012439A (https=)
NO (1) NO20050063L (https=)
PL (1) PL374551A1 (https=)
UY (1) UY27841A1 (https=)
WO (1) WO2003104227A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
CN1675204A (zh) * 2002-06-10 2005-09-28 拜耳医药保健股份公司 2－杂芳基甲酰胺
MXPA05003317A (es) 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
DE602004031124D1 (de) 2003-08-13 2011-03-03 Neurosearch As Neue chinuklidinderivative und deren pharmazeutische verwendung
DE602004010299T2 (de) 2003-12-22 2008-09-18 Memory Pharmaceuticals Corp. Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen
NZ550534A (en) * 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
JP2007538046A (ja) 2004-05-19 2007-12-27 ノイロサーチ アクティーゼルスカブ 新規なアザビシクロアリール誘導体
EP1802616B1 (en) 2004-10-15 2011-01-12 NeuroSearch A/S Novel azabicyclic aryl derivatives and their medical use
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
US8410277B2 (en) 2007-12-26 2013-04-02 Eisai R&D Managment Co., Ltd. Method for manufacturing heterocycle substituted pyridine derivatives
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
AR081402A1 (es) 2010-05-17 2012-08-29 Envivo Pharmaceuticals Inc Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato
CA2821480A1 (en) 2010-12-20 2012-06-28 Astrazeneca Ab 2-carboxamide-4-piperazinyl-benzofuran derivative
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
EP4213832A4 (en) * 2020-09-18 2024-10-16 Merck Sharp & Dohme LLC Modified benzofuran-carboxamides as glucosylceramide synthase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
HUP0402289A2 (hu) * 2001-10-02 2005-02-28 Pharmacia & Upjohn Company Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE10164139A1 (de) * 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
CN1675204A (zh) * 2002-06-10 2005-09-28 拜耳医药保健股份公司 2－杂芳基甲酰胺
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法

Also Published As

Publication number Publication date
CA2488761A1 (en) 2003-12-18
US20120258964A1 (en) 2012-10-11
CA2488761C (en) 2011-05-31
US9067931B2 (en) 2015-06-30
JP4542891B2 (ja) 2010-09-15
AU2003238450A1 (en) 2003-12-22
UY27841A1 (es) 2003-12-31
PL374551A1 (en) 2005-10-31
US7977485B2 (en) 2011-07-12
ATE344262T1 (de) 2006-11-15
DE50305587D1 (en) 2006-12-14
BR0312446A (pt) 2005-04-19
JP2005533052A (ja) 2005-11-04
EP1515967B1 (de) 2006-11-02
US20140350008A1 (en) 2014-11-27
US20060160877A1 (en) 2006-07-20
MXPA04012439A (es) 2005-04-19
US20110263591A1 (en) 2011-10-27
WO2003104227A1 (de) 2003-12-18
US20160122337A1 (en) 2016-05-05
IL165505A0 (en) 2006-01-15
NO20050063L (no) 2005-01-06
US10214524B2 (en) 2019-02-26
EP1515967A1 (de) 2005-03-23
ES2276072T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
CN1675204A (zh) 2－杂芳基甲酰胺
CN100345847C (zh) 新的联芳基甲酰胺
CN1250545C (zh) 新的奎宁环衍生物类及含有这类衍生物的药物组合物
CN1192021C (zh) 作为阿片受体配体的3－氮杂二环[3.1.0]己烷衍生物
CN1976701A (zh) 毒蕈碱性乙酰胆碱受体拮抗剂
CN1234708C (zh) 新的咪唑并三嗪酮类化合物及其应用
CN1950089A (zh) 吗啉化合物
CN1933830A (zh) 吲哚衍生物和其作为激酶抑制剂特别是ikk2抑制剂的用途
CN1946725A (zh) 用作细胞周期蛋白依赖激酶抑制剂的新型吡唑并嘧啶
CN1440410A (zh) 二氮杂二环中枢神经系统活性剂
CN1802373A (zh) 作为激酶抑制剂的吡唑并异喹啉衍生物
CN1946703A (zh) 取代的噻唑和嘧啶衍生物作为黑素细胞皮质激素受体调节剂
CN1684962A (zh) 吲唑、苯并噻唑和苯并异噻唑，以及它们的制备和用途
CN1571787A (zh) 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途
CN1541214A (zh) 新化合物
CN1922176A (zh) 稠合的双环杂环取代的奎宁环衍生物
CN1662527A (zh) 作为m3毒蕈碱性受体拮抗剂的吡咯烷鎓衍生物
CN1976915A (zh) Hiv整合酶抑制剂
CN1139928A (zh) 新化合物
CN1880317A (zh) 作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶
CN1639141A (zh) 新的噻二唑和噁二唑及其作为磷酸二酯酶－7抑制剂的用途
CN1930160A (zh) Hiv整合酶抑制剂
CN101039672A (zh) 化合物
CN1740169A (zh) 用作类胰蛋白酶抑制剂的芳基甲胺衍生物
CN1084846A (zh) 乙醇胺衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1083506

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1083506

Country of ref document: HK